Gene · 4481
Papers3,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ferritin-mediated neutrophil extracellular traps formation and cytokine storm via macrophage scavenger receptor in sepsis-associated lung injury. | Cell Commun Signal | 2024 | 38308264 | PubTator, text mining | PubMed |
| Identification and validation of a 4-extracellular matrix gene signature associated with prognosis and immune infiltration in lung adenocarcinoma. | Heliyon | 2024 | 38293522 | PubTator, text mining | PubMed |
| Tumor microenvironment of cancer stem cells: Perspectives on cancer stem cell targeting. | Genes Dis | 2024 | 38292177 | PubTator, text mining | PubMed |
| VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation. | Nat Commun | 2024 | 38291039 | PubTator, text mining | PubMed |
| Aseptic loosening around total joint replacement in humans is regulated by miR-1246 and miR-6089 via the Wnt signalling pathway. | J Orthop Surg Res | 2024 | 38287447 | PubTator, text mining | PubMed |
| Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions. | Genome Med | 2024 | 38281962 | PubTator, text mining | PubMed |
| Functional role of Ash2l in oxLDL induced endothelial dysfunction and atherosclerosis. | Cell Mol Life Sci | 2024 | 38280036 | PubTator, text mining | PubMed |
| The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma. | J Cancer Res Clin Oncol | 2024 | 38279987 | PubTator, text mining | PubMed |
| Epigallocatechin-3-Gallate and Genistein for Decreasing Gut Dysbiosis, Inhibiting Inflammasomes, and Aiding Autophagy in Alzheimer's Disease. | Brain Sci | 2024 | 38275516 | PubTator, text mining | PubMed |
| TP53 to mediate immune escape in tumor microenvironment: an overview of the research progress. | Mol Biol Rep | 2024 | 38270700 | PubTator, text mining | PubMed |
| Evaluating the State of Glomerular Disease by Analyzing Urinary Sediments: mRNA Levels and Immunofluorescence Staining for Various Markers. | Int J Mol Sci | 2024 | 38255818 | PubTator, text mining | PubMed |
| Biophysical Control of the Glioblastoma Immunosuppressive Microenvironment: Opportunities for Immunotherapy. | Bioengineering (Basel) | 2024 | 38247970 | PubTator, text mining | PubMed |
| Fatty acid metabolism of immune cells: a new target of tumour immunotherapy. | Cell Death Discov | 2024 | 38245525 | PubTator, text mining | PubMed |
| The roles of tissue resident macrophages in health and cancer. | Exp Hematol Oncol | 2024 | 38229178 | PubTator, text mining | PubMed |
| Pathological complete response to neoadjuvant chemotherapy may improve antitumor immune response via reduction of regulatory T cells in muscle-invasive bladder cancer. | Sci Rep | 2024 | 38228697 | PubTator, text mining | PubMed |
| In Vitro Targeted Delivery of Simvastatin and Niacin to Macrophages Using Mannan-Grafted Magnetite Nanoparticles. | ACS Omega | 2024 | 38222576 | PubTator, text mining | PubMed |
| Early involvement of peripherally derived monocytes in inflammation in an NMO-like mouse model. | Sci Rep | 2024 | 38216632 | PubTator, text mining | PubMed |
| The aging mouse CNS is protected by an autophagy-dependent microglia population promoted by IL-34. | Nat Commun | 2024 | 38195627 | PubTator, text mining | PubMed |
Oxidized Low-Density Lipoprotein Accumulation in Macrophages Impairs Lipopolysaccharide-Induced Activation of AKT2, ATP Citrate Lyase, Acetyl-Coenzyme A Production, and Inflammatory Gene H3K27 Acetylation. | Immunohorizons | 2024 | 38193847 | PubTator, text mining | PubMed |
| Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities. | Biomark Res | 2024 | 38185636 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4481/papers?page=11